Development
PROCEPT BioRobotics Corporation
PRCT
$62.91
-$2.14-3.29%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -21.51% | -37.81% | -51.93% | -53.32% | -45.61% |
| Total Depreciation and Amortization | 34.00% | 7.17% | -7.68% | -9.19% | -14.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.33% | 128.23% | 205.95% | 260.55% | 295.13% |
| Change in Net Operating Assets | -127.75% | -284.30% | -404.97% | -372.77% | -144.04% |
| Cash from Operations | -34.36% | -51.20% | -69.22% | -62.47% | -40.20% |
| Capital Expenditure | -850.09% | -719.11% | -1,728.35% | -1,205.43% | -348.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -850.09% | -719.11% | -1,728.35% | -1,205.43% | -348.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,514.85% | 2,885.58% | -97.15% | -96.88% | -96.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,545.49% | 2,835.25% | -98.73% | -98.97% | -98.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.55% | 155.50% | -205.72% | -151.35% | -138.90% |